CDC Panel Recommends Fourth COVID Vaccine for Use in the US
The U.S. Centers for Disease Control and Prevention Advisory Committee on Immunization Practices on Tuesday recommended the Novavax COVID-19 vaccine for use as a primary series in adults aged 18 years and older.
“If you have been waiting for a COVID-19 vaccine built on a different technology than those previously available, now is the time to join the millions of Americans who have been vaccinated,” said Rochelle Walensky, who serves as director of the CDC, in a written statement.
The Novavax vaccine uses proteins of COVID-19 virus alongside another ingredient, called an adjuvant, to help the immune system respond to the virus in the future.
The White House released a statement on Tuesday following the CDC recommendation and the emergency use authorization granted by the Food and Drug Administration on July 13. So far, the U.S. has 3.2 million doses to be rolled out in the coming weeks.
Alexa can be reached at [email protected]
